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Aspartame in conjunction with alcohol has been shown to increase the blood alcohol level in 
humans faster than alcohol and sucrose (Wu et al., 2006).  To determine the potential effects of 
various mixtures of ethanol and aspartame on the nervous system, the heart rate of Daphnia 
magna (D.magna, water flea) was measured in deionized water (control), ethanol, aspartame, 
and  five  different  mixtures  of  ethanol  and  aspartame.    The  heart  rate  was  chosen  as  a 
representative measure since it is controlled by the nervous system and the heart rate of D. 
magna can easily be measured. The results were statistically evaluated by student’s t-test. A 
significant increase in heart rate was observed for all mixed assays compared to both control and 
ethanol, but not to aspartame. The data suggests that the aspartame and alcohol mixture have a 
greater effect on D. magna heart rate than water or ethanol, but not aspartame alone. We propose 
that alcohol in combination with aspartame has potentially detrimental consequences for the 
nervous system.  
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Introduction 
 
Stimulants and depressants, specifically 
aspartame and alcohol, have been the focal point 
in  many  scientific  studies  both  in  conjunction 
with  each  other  and  as  separate  entities.    The 
combination  of  aspartame  and  alcohol  has 
resulted in a marked increase in blood alcohol 
levels when compared to alcohol and sugar (Wu 
et  al.,  2006).  Anecdotal  reports  suggest  that 
alcohol  and  aspartame,  a  component  of  diet 
sodas, are popular, particularly among women, 
to  minimize  the  caloric  intake  of  mixed 
alcoholic beverages (Henkel, 1999).   
 
Aspartame 
Aspartame, an artificial sweetener, was 
approved  by  the  U.S.  Food  and  Drug 
Administration in 1981 and has been used as a 
tabletop  sweetener  and  in  beverages,  breakfast 
cereals,  desserts,  and  chewing  gum  since  then 
(Henkel,  1999).  Aspartame  consumption  has 
been  shown  to  cause  neurological  and 
behavioral  symptoms  in  certain  individuals 
ranging from headaches and mood alterations to 
dizziness and insomnia (Bradsiock et al., 1986).  
These symptoms are thought to result from the 
role  each  component  of  aspartame  plays  once 
entering the body (Butchko et al., 2002).   
Fifty percent of aspartame is comprised 
of  phenylalanine,  which  is  either  converted  in 
the liver to tyrosine (a non-essential amino acid) 
or  remains  unchanged.    In  order  for  either 
tyrosine  or  phenylalanine  to  cross  the  blood 
brain barrier (BBB), binding to a large neutral 
amino  acid  transporter  (NAAT)  must  occur 
(Humphries  et  al,  2008).    Since  NAAT  is  the 
only way in which phenylalanine, tyrosine, and 
other  amino  acids  can  cross  the  BBB,  a  great 
deal of competition exists for the limited binding 
sites  (Humphries  et  al.,  2008).    Increased 
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sites  occupied  by  phenylalanine,  therefore 
inhibiting  the  transportation  of  other  essential 
neutral amino acids into the brain. (Yokogoshi et 
al., 1984; Coulombe and Sharma, 1986).  The 
increase of phenylalanine in the brain has been 
seen to cause a phenylketonuria effect, which is 
a  hereditary  disorder  characterized  by  the 
accumulation of phenylalanine (Mehl-Madrona, 
2005).    This  results  in  a  decrease  in  the 
dopamine  and  serotonin  production  and  since 
serotonin  plays  a  critical  role  in  behavior, 
control  of  sleep,  appetite,  and  neuroendocrine 
function, a decrease in serotonin levels will have 
effects  on  these  behaviors  (Humphries  et  al., 
2008).   
Aspartic acid, also known as aspartate, 
is  an  excitatory  neurotransmitter  in  the  central 
nervous  system  (CNS)  and  comprises  40%  of 
aspartame.  Aspartic acid increases depolariza-
tion  at  the  postsynaptic  membrane.    The 
increased  depolarization  can  induce 
neuroendocrine disturbances and the rapid firing 
of  neurons  ultimately  results  in  the  failure  of 
enzymes to function optimally (Humphries et al., 
2008).  Unlike other amino acids in the brain, 
aspartic acid is not one of the essential amino 
acids.    As  a  result  of  the  excitatory  effects  of 
aspartic acid, the concentration in the brain must 
be  controlled  to  prevent  excess  stimulation  of 
the nerve cells (Magnuson, 2007).  
Methanol,  constituting  10%  of 
aspartame,  is  poisonous  at  temperatures  above 
86°F  and  therefore  becomes  toxic  once 
aspartame  is  ingested.    Methanol  is  found 
naturally in fruits and vegetables, but in that case 
it is bound to pectin.  When it is bound to pectin, 
the body is unable to break down the molecule 
and therefore the methanol is never released into 
the bloodstream (Thomas, 2005). In aspartame, 
methanol is not bound to pectin and is therefore 
considered to be in its “free” form.  In this case, 
the methanol is released to a greater degree and 
at  an  increased  rate  (Magnuson,  2007).    The 
methanol  present  from  the  breakdown  of 
aspartame  is  converted  in  the  liver  to 
formaldehyde, which is a known neurotoxin and 
carcinogen  (Humphries  et  al.,  2008).  
Formaldehyde  is  further  broken  down  into 
formic  acid,  which  accumulates  in  the  brain, 
kidneys, spinal fluid, and other organs and can 
lead  to  excess  acid  in  body  fluids,  which  is 
known  as  acidosis  (Humphries  et  al.,  2008).  
Methanol poisoning has been shown to result in 
dizziness, headaches, and behavioral alterations, 
which  are  all  effects  that  have  been  reported 
from aspartame consumption (Thomas, 2005).    
Several  studies  have  shown  the 
detrimental effects of aspartame metabolites on 
the nervous system.  One specific study on the 
acetylcholinesterase  of  the  frontal  cortex  of 
suckling  rats  concluded  that  the  increased 
concentration of metabolites in the bloodstream 
resulted  in  seizures,  memory  loss,  headaches, 
and cholinergic defects (Simintzi et al., 2007). 
This  led  researchers  to  conclude  that  high 
dosages  (toxic  levels)  of  aspartame  are 
detrimental to the nervous systems of the rats, 
even though the consumption of normal levels of 
aspartame  showed  little  effect  on  their  frontal 
cortex.  Interestingly,  aspartame  itself  had  little 
effect, but the metabolites were responsible for 
the decreased enzymatic activity (Simintzi et al., 
2007).  Not only has aspartame been shown to 
have  an  effect  on  enzyme  activity,  but  it  has 
been  suggested  to  disrupt  the  metabolism  of 
amino acids, protein structure, neuronal function, 
and  catecholamine  concentrations  in  the  brain 
(Humphries et al., 2008).  
 
Alcohol 
Heavy  alcohol  consumption  has  been 
shown  to  cause  depressive  episodes,  severe 
anxiety, insomnia, temporary cognitive defects, 
and  peripheral  neuropathy  (Schuckit,  2009).  
Once alcohol is consumed, about 98% enters the 
bloodstream  through  the  walls  of  the  small 
intestine (Schuckit, 2009).   
Alcohol,  regardless  of  the  dose, 
enhances  the  activity  in  the  inhibitory  γ-
aminobutyric acid (GABA) systems throughout 
the  brain  (Schuckit,  2009).    GABA  is  an 
inhibitory neurotransmitter that binds to specific 
transmembrane  receptors  in  the  plasma 
membrane of the pre-synaptic and post-synaptic 
neurons.    Upon  binding,  ion  channels  open 
resulting  in  the  influx  of  chloride  ions  or  the 
efflux  of  potassium  ions.    When  alcohol  is 
introduced into the system, the inhibitory action 
of GABA is augmented.   Since GABA is not 
present in one specific location in the brain, but 
rather  in  several  locations,  the  presence  of 
alcohol  inhibits  several  activities  in  the  brain Page 3 of 9 
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resulting in behavioral changes including muscle 
relaxation and somnolence (Schuckit, 2009).   
Alcohol consumption also stimulates the 
neurons  of  the  serotonergic  system,  which  is 
located in the raphe nucleus at the base of the 
brain  (Schuckit,  2009).    This  area  influences 
brain  functions  that  are  related  to  attention, 
emotions,  and  motivation  (Lovinger,  1991).  
Studies  have  shown  that  individuals  who 
consume  large  amounts  of  alcohol  have 
differences  in  brain  serotonin  levels  in 
comparison to non-alcoholics (Lovinger, 1991).  
Lovinger (1991) also showed that both short and 
long term exposure of alcohol has an effect on 
the  serotonin  receptors  that  convert  the  signal 
produced by serotonin into functional changes in 
the signal-receiving cell.Even a single exposure 
to alcohol has an effect on the synaptic functions 
of serotonin.  Upon alcohol ingestion, levels of 
serotonin  metabolites  in  the  urine  and  blood 
increase,  indicating  an  increase  in  serotonin 
release from the nervous system.  This has been 
suggested  to  be  a  result  of  enhanced  signal 
transmission at serotonergic synapses (Lovinger, 
1991).    Research  investigating  the  effects  of 
ethanol on the nervous system has shown that 
alcohol  has  the  ability  to  disrupt  an  active 
fragment  of  the  activity-dependent  neuro-
protective  protein  (ADNP)  called  NAPVSIPQ 
(NAP) (Chen and Charness, 2008). NAP is an 
octapeptide  that  is  necessary  in  signaling  Fyn 
Kinase  (a  member  of  the  Scr  Family  Kinase), 
resulting in normal axonal outgrowth in cerebral 
granule  cells,  found  in  the  brain  (Chen  and 
Charness, 2008). NAP has been shown to protect 
the  nervous  system  against  a  wide  variety  of 
insults, including alcohol exposure.  Therefore, 
disrupting the activity of NAP and the presence 
of  excess  ethanol  due  to  social  drinking  in 
humans  have  resulted  in  neuronal  migratory 
malfunctions,  improper  axonal-dendritic 
connections,  as  well  as  apoptosis  of  glial  and 
neuronal  progenitor  cells  (Chen  and  Charness, 
2008). 
 
Alcohol and Aspartame 
In  recent  years,  “sugar-free”  alcoholic 
beverages  have  become  more  popular,  but 
consuming  alcoholic  beverages  that  contain 
aspartame  in  place  of  sucrose  may  result  in  a 
greater  degree  of  adverse  effects  (Wu  et  al, 
2006).  Participants  in  a  study  who  consumed 
“diet-alcoholic”  drinks  containing  aspartame 
were found to have higher blood-alcohol levels 
when  compared  to  those  consuming  alcoholic 
drinks containing sucrose (Wu et al, 2006).  In 
addition, alcohol, like aspartame, has been found 
to  affect  heart  rate.  Alcohol  has  a  depressive 
effect on the nervous system by first depressing 
the  highest  cerebral  centers  of  the  brain 
(prefrontal  cortex)  then  the  motor  and  sensory 
centers, the cerebellum, spinal cord and finally 
the  medulla  (Karpas,  1916).  The  medulla  is 
responsible for controlling breathing, heart rate 
and other basic involuntary functions in the body. 
By depressing this part of the brain, alcohol can 
also reduce heart rate. 
Since  the  heart  rate  is  modulated  by 
different parts of the brain, the heart rate can be 
used  in  order  to  determine  the  effect  of 
aspartame  and  alcohol,  both  combined  and  as 
separate  entities,  on  the  nervous  system 
(Guyenet, 1990).  
The  small  fresh  water  crustacean,  D. 
magna, was used in this experiment because of 
their  transparent  carapace,  which  allows  for 
increased  visibility  of  the  internal  organs  and 
makes monitoring the heart rate of the individual 
easier  (Environmental  Inquiry,  2006).    It  was 
hypothesized  that  treatment  with  aspartame  (a 
stimulant)  alone  would  increase  the  heart  rate 
while  treatment  with  alcohol  (a  depressant) 
would depress the heart rate.  Since alcohol and 
aspartame have opposite effects on the nervous 
system,  it  was  thought  that  the  combination 
would result in a heart rate comparable to the 
base  heart  rate  of  D.  magna.  D.  magna  were 
treated with alcohol and aspartame alone and in 
different combinations to determine the effect on 
the nervous system. 
Materials and Methods 
 
Daphnia magna 
All  D. magna  used  in  this  experiment 
were  purchased  through  Ward’s  Natural 
Science©  and  housed  in  containers  containing 
spring  water.      D.  magna  utilized  were  of 
different sizes and states of maturity.  
 
Ethanol Solutions 
Preliminary  tests  showed  that  a  2.0% 
alcohol stock solution, manufactured by Ward’s Page 4 of 9 
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Natural Science© (Rochester, New York), was 
fatal for D. magna, but 0.2% elicited a decrease 
in heart rate without fatalities. Four successive 
ethanol dilutions in deionized water were then 
prepared: 34.32 mM (0.2%), 17.16 mM (0.1%), 
8.58 mM (0.05%), and 4.29 mM (0.025%). The 
amount  of  alcohol  ingested  could  not  be 
determined since the alcohol level in the fleas 
could not be measured.  Forty D. magna were 
used  in  the  ethanol  assays,  n=10  for  each 
concentration. 
 
Aspartame Solutions 
Equal®  was  used  as  the  source  of 
aspartame.  Three  solutions  with  the  following 
concentrations; 10.0 mM, 1.0 mM, and 0.1 mM 
in  deionized  water  were  prepared.  It  has  been 
discussed  that,  in  humans,  aspartame  only  has 
negative effects at levels much higher that the 
recommended 40 – 50 mg/kg body weight/ day 
(Magnuson, 2007). Thus, a high concentration of 
aspartame was chosen for the initial assay. The 
solubility of aspartame is about 30 g/L at room 
temperature. Considering a molecular weight of 
294.31 g/mole for aspartame, a starting solution 
of  10.0  mM  was  close  to  the  maximum 
concentration at room temperature. It is difficult 
to  judge  how  much  of  the  compound  was 
ingested by D. magna, but based on an estimated 
average body weight of 30.0 mg, the organisms 
were exposed to 49.05 g/kg body weight (10.0 
mM),  4.905  g/kg  body  weight  (1.0  nM),  and 
0.49  g/kg  body  weight  (0.1  mM).    Thirty  D. 
magna were used in the ethanol assays, n=10 for 
each concentration. 
 
 
 
Mixed Assays 
Five  mixed  assays  were  made  from 
initial  concentrations  of  34.32  mM  (0.2%) 
ethanol  and  10.0  mM  aspartame.  The 
concentration  of  ethanol  in  each  successive 
mixture  decreased  while  the  aspartame 
concentration increased (Table 1). This type of 
varying solution was chosen to parallel alcoholic 
drinks  with  diet  soda,  since  the  proportion  of 
alcohol in those drinks varies inversely with the 
amount  of  aspartame.    Similarly,  in  this 
experiment  the  volume  of  liquid  the  organism 
was  exposed  to  was  limited.  One-hundred  and 
twenty D. magna were used in the mixed assays. 
For Assay # 1 n=21, for Assay # 2 n=21, for 
Assay # 3 n=22, for Assay 4#  n=29, and for 
Assay # 5 n=27.  
 
 
 
 
Assay #  Ethanol (mM)  Aspartame (mM) 
1  30.89  1.0 
2  24.02  3.0 
3  17.16  5.0 
4  10.30  7.0 
5  3.43  9.0 
 
Heart Rate Acquisition 
Each  D.  magna  was  chosen  randomly 
and removed from a jar of fresh water with a 
plastic pipette and transferred individually onto 
a  concave  microscope  slide.    Any  water 
remaining  on  the  slide  was  entirely  absorbed 
with  a  paper  towel.  Then  D.  magna  were 
submerged in 50.0 µL of one of the following: 
deionized water for the base heart rate, alcohol 
solutions, aspartame solutions, or mixed assays.  
Subsequently,  D.  magna  were  allowed  to 
acclimatize to the environment for two minutes, 
and  then  the  heart  rate  was  counted  for  one 
minute. Heart rate was recorded with the use of 
a  hand  held,  manual  counter.  A  different  D. 
magna was used for each assay.  
The  base  heart  rate  was  acquired  by 
transferring each D. magna into deionized water, 
allowing it to acclimatize for two minutes, and 
recording heart rates for one minute. Statistical 
analysis  was  performed  similarly  in  the  other 
parts of the experiment.  Fifty D. magna were 
used for the base heart rate assay. 
 
Statistical Analysis 
The  average  heart  rate  and  standard 
error  of  the  mean  (SEM)  were  calculated  for 
each  concentration  of  each  part  of  the 
experiment  (ethanol,  aspartame,  and  mixed 
assays). Statistical significance at α = 0.05 and 
α = 0.01 was evaluated using the student’s t-test. 
All  calculations  were  performed  on  the 
statistical software SPSS. 
 
 
Table 1. Mixed assay concentrations for ethanol and 
aspartame in 50 µL. Page 5 of 9 
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Figure 1. Daphnia magna heart rate change in 
ethanol. Heart rate in increasing ethanol concentrations 
was compared to base rate. Generally, a depressant 
trend was seen, but only concentrations 17.16 and 34.43 
mM decreased heart rate significantly. 34.32 mM was 
used for subsequent testing. Error is SEM, n = 10 for 
each concentration, n = 50 for BR; * = p < .01.  
Figure 2. D. magna heart rate change in aspartame. D. 
magna heart rate was significantly increased from base 
rate in 10.0 mM aspartame but not in any of the two 
lower concentrations. Thus, in subsequent testing 10.0 
mM of aspartame concentration was used. Bars represent 
SEM; n = 10 for 10.0 mM and 0.1 mM; n = 11 for 
concentration 1.0 mM; * = p < .01 
Results  
 
Base Heart Rate 
To compare the effects of aspartame and 
alcohol on the cardiac activity of D. magna, a 
base  heart  rate  (BR)  of  204  +/-  7  beats  per 
minute (bpm) was established (n=50).  
 
Heart Rate in Ethanol 
In  order  to  evaluate  changes  in  D. 
magna  heart  rate  in  ethanol  the  fleas  were 
exposed  to  increasing  ethanol  concentrations 
(4.29, 8.58, 17.16, and 34.32 mM). The alcohol 
showed an overall depressive trend on heart rate. 
However, only ethanol concentrations 17.16 and 
34.32  mM  showed  a  significant  decrease  with 
total heart rates of 180 +/- 4 bpm (t (54.7) = 3.24, 
p < .01, n = 10) and 133 +/- 8 bpm (t (23.32) = 
6.95, p < .01,    n = 10) respectively (Fig. 1). For 
further investigation, an ethanol concentration of 
34.32 mM was utilized to capitalize on the most 
pronounced  depressive  effect  of  this 
concentration.   
 
Heart Rate in Aspartame 
To  assess  changes  of  heart  rate  in 
aspartame  three  different  concentrations  of 
aspartame were examined (10.0 mM, 1.0 mM,  
 
and 0.1 mM). When D. magna was submerged 
in aspartame, the fleas tended to exhibit higher 
heart  rates  with  increasing  concentrations, 
compared to base rate (Fig. 2).  When compared 
to the base rate the highest increase in heart rate 
was  observed  at  a  concentration  of  10.0  mM 
with a heart rate of 243 +/- 9 bpm (t (30.6) =  
-4.09, p < .01, n=10) (Fig. 2).  
 
Heart Rate in Mixed Assay 
To  evaluate  possible  influences  of 
ethanol in combination with aspartame on heart 
rate, a series of mixed assays were administered 
(Table  1).  The  base  solutions  for  the  mixed 
assays  were  34.32  mM  ethanol  and  10.0  mM 
aspartame,  which  were  chosen  because  each 
caused the greatest depression or stimulation of 
heart rate respectively.  
Both  ethanol  and  aspartame  were 
observed  to  be  different  from  base  rate,  as 
mentioned before. When compared to base rate, 
Assays # 1 through # 5 also showed significant 
differences with Assay #1 at 250 +/- 3 bpm (t 
(66.12) = -6.26, p < .01, n = 21), Assay # 2 at 
248 +/- 4 bpm (t (68.82) = -5.50, p < .01, n = 21), 
Assay # 3 at 233 +/- 4 bpm (t (69.97) = -3.63, p 
< .01, n = 22), Assay # 4 at 231 +/- 3 bpm (t 
(63.68) = -3.67, p < .01, n = 29), and Assay # 5 
at 234 +/- 5 bpm (t (74.98) = -3.63, p < .01, n = 
27) (Fig. 3, significance denoted by *).  
Increases in heart rate were found for all 
combination  assays,  when  compared  to  heart 
rate in ethanol alone (Assay # 1 with t ( 29) = Page 6 of 9 
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16.38, p < .01; # 2 with t (29) = 13.68, p < .01; 
Assay # 3 with t ( 30) = 11.93, p < .01; Assay # 
4 with t (37) = 15.07, p < .01, and Assay # 5 
with t (35) = 10.838, p < .01) (Fig. 3, depicted 
by 
o).  
When  comparing  each  assay  with  its 
successive assay (Assay # 1 with # 2, Assay # 2 
with # 3, Assay # 3 with # 4, and Assay # 4 with 
#  5),  only  Assay  #  3  was  observed  to  be 
significantly different from its preceding Assay 
# 2 (t ( 41) = 2.39, p < .05) (Fig. 3, denoted by 
+). 
Heart rate in aspartame was not different from 
any of Assays # 1-5 (Fig. 3).   
 
 
Discussion 
 
In  the  first  experiments  conducted 
(ethanol  assay),  a  decrease  in  heart  rate  was 
observed with increasing ethanol concentrations 
demonstrating  that  ethanol  has  a  depressive 
effect on heart rate. Heart rate was considered 
representative  of  the  actions  on  the  nervous 
system  for  the  purpose  of  this  experiment 
because  the  heart  rate  is  regulated  by  the 
nervous  system  in  D.  Magna,  and  therefore 
changes  in  heart  rate  were  used  to  assess 
changes  in  nervous  system  activity  (Guyenet, 
1990). 
The  second  part  of  the  experiment,  in 
which  D.  magna  were  introduced  to  various 
concentrations  of  aspartame,  resulted  in  an 
increase  in  heart  rate  as  the  concentration  of 
aspartame  solutions  increased,  confirming  the 
stimulant effect of aspartame.    
In  the  final  part  of  the  experiment, 
mixed  assays  of  aspartame  and  ethanol  were 
used  to  determine  the  combined  effects  of  a 
stimulant and a depressant.  The results of the 
mixed assay (Fig. 3) showed a marked increase 
of  D.  magna  heart  rate  with  even  a  minimal 
addition  of  aspartame  to  ethanol  (Assay  #  1). 
These  findings  suggest  that  the  ingestion  of 
aspartame has a greater impact on heart rate than 
alcohol.  There  was  no  systematic  difference 
among  Assays  #1  –  5  or  when  comparing  the 
assays with aspartame alone. This may indicate 
that  any  amount  of  aspartame  in  combination 
with  alcohol  has  a  significant  influence  on  D. 
magna  metabolism  and  heart  rate.  The 
difference  between  Assays  #  2  and  #  3  could 
potentially  be  eliminated  with  further  testing. 
The  results  obtained  could  be  due  to  a  novel 
metabolic  pathway  involved  in  the  combined 
processing of ethanol and aspartame or due to 
the  aspartame  pathway  that  could  partially 
override the depressive effect of alcohol.  
The  nervous  system  activity  of  D. 
magna,  gauged  by  cardiac  output,  was  greatly 
affected  by  the  introduction  of  a  stimulant,  a 
depressant,  and  a  combination  of  both.  D. 
magna,  has  become  an  established  model 
organism  because  they  are  easily  cultured  and 
have short reproductive cycles. While the main 
areas of focus on D. magna as a model organism 
lie in ecology and evolution, it has been shown 
that the crustacean exhibits about a 55% genetic 
homology  with  humans,  suggesting  it  to  be 
eligible  as  a  model  for  some  for  human 
processes (Gilbert, 2007).   
The  experiments  conducted  were  to 
understand the side effects and the mechanisms 
that underlie the process of how stimulants and 
depressants  affect  nervous  system  activity. 
Previous research on stimulants has found that 
they  increase  CNS  or  sympathetic  nervous 
system activity with a spectrum of effects such 
as  cardiovascular  stimulation  and  increased 
energy levels (Rothman and Baumann, 2003). In 
the  presence  of  stimulants,  synaptic  levels  of 
monoamine  neurotransmitters  are  elevated  in 
neurons,  specifically  dopamine,  serotonin,  and 
norepinepherin  (Sofuoglu  and  Sewell,  2008). 
Neurotransmitter  concentrations  increase  as  a 
result of blocking transporter–mediated reuptake 
inhibitors  from  the  synapse  (Rothman  and 
Baumann,  2003).    Excess  levels  of  serotonin 
have  been  associated  with  cardiac  and 
pulmonary  disease,  and  stimulants  such  as 
amphetamine  analogs  act  as  substrates  for  the 
serotonin  transporters,  which  release  serotonin 
from  platelets,  in  turn  elevating  plasma  blood 
levels of the neurotransmitter (Zolkowska et al., 
2006).    Plasma  serotonin  stimulates  mitogenic 
activity from cardiovascular cells (Zolkowska et 
al., 2006).  
Depressants  also  affect  CNS  activity 
through  different  mechanisms.  Ethanol,  a 
depressant,  enhances  GABAergic  synaptic 
inhibition by means of allosteric potentiation of 
postsynaptic  GABA  receptors  (Ariwodola  and 
Weiner,  2004).  This  mechanism  plays  a  vital Page 7 of 9 
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role in the effects of ethanol, most notably on 
cognition.  GABA receptors are responsible for 
mediating fast synaptic inhibition. Hippocampal 
GABA activity is potentiated by ethanol when 
there  is  a  blockade  of  GABA  B  receptors 
(Ariwodola  and  Weiner,  2004).    Ethanol  was 
also found to increase GABAergic transmission 
into  the  ventral-tegmental  area  dopaminergic 
neurons,  in  which  GABA  inhibitory  post 
synaptic  currents  are  enhanced  (Theile  et  al., 
2008).  The  increase  of  overall  GABA  in  the 
CNS  produces  a  decrease  in  cardiovascular 
activity (Segura and Haywood, 1991).   
Considering  the  large  increase  in  D. 
magna heart rate in all five mixed assays, further 
investigation appears to be warranted aimed at 
identifying  similar  effects  in  larger  organisms 
like  mice,  and  eventually  in  humans.  
Examination  of  larger  animals  would  allow 
controlling the amount of ingested alcohol and 
aspartame. Memory or behavior tasks could then 
be used to evaluate other effects of the mixture 
on  nervous  system  functions.  Furthermore, 
neurotransmitter  levels  in  the  brain  of  these 
animals  could  be  measured.  The  results  could 
shed  light  on  the  pathways  involved  in  the 
metabolism  of  alcohol  in  conjunction  with 
aspartame.  We  also  suggest  investigating  the 
effect of aspartame doses that come closer to the 
maximum  recommended  amount  of  40  –  50 
mg/kg body weight/day. 
Further  research  on  the  effects  of 
aspartame and alcohol, similar to our experiment, 
should  be  particularly  directed  towards 
individuals who consume beverages containing 
aspartame and/ or alcohol.  In one survey, two 
out of every five students were found to binge 
drink  (Wechsler  et  al.,  1998)  and  research 
studies  surveying  the  dietary  habits  of  female 
college  students  (43%),  found  that  artificial 
sweeteners  (specifically  aspartame)  were 
frequently  used  to  reduce  weight  gain  in 
combination  with  other  dietary  methods 
(Malinauskas et al., 2006). Since both aspartame 
and alcohol are consumed on college campuses, 
the  target  population  for  future  research  could 
encompass  college  students  and  long-term  or 
short-term  effects  of  alcohol/aspartame 
consumption on the nervous system  
Though our research was not conducted 
on humans, D. magna nervous system research 
provides a basis for understanding the possible 
side  effects  of  excessive  consumption  of 
aspartame in conjunction with alcohol. Human 
studies  have  shown  that  aspartame  can  cause 
migraines,  seizures,  depression  and  anxiety 
(Bradsiock et al., 1986). Alcohol has been linked 
to  depression,  anxiety  and  cognitive  deficits 
(Schuckit, 2009). Thus temporary or long-term 
nervous  system  alterations  by  alcohol  and 
aspartame  may  cause  serious  health  risks  that 
have not yet been identified but could become 
manifest  with  increasing  consumption  of 
aspartame in the future. 
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